TSRO Tesaro, Inc.

This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (December 4, 2018).

Global stocks and oil prices flew higher after an easing of geopolitical tensions, but bond investors signaled that the anxiety that has gripped markets for the past two months has yet to abate. The Dow and S&P 500 both climbed 1.1%.

Oil notched its best day in more than five months, surging 4%.

A judge questioned the Justice Department's approval of CVS's Aetna takeover and may halt the companies' integration while he reviews the merger.

Glaxo said it would buy cancer-focused drug company Tesaro for about $4.16 billion.

Shareholder pushback has led Disney to increase the targets CEO Iger must meet to collect his $100 million performance bonus.

Tencent Music is moving forward with its plans for an IPO in the U.S. after pausing the process a couple of months ago because of a stock-market selloff.

Chinese regulators have significantly slowed approving independent movies imported from the U.S., the latest sign of tension between Hollywood and Beijing.

Shell plans to set short-term carbon-emissions targets and link them to executive pay, capitulating to investor pressure.

China's project to replace gasoline-fueled taxis, buses and trucks with electric models is boosting its ambitions to lead the shift to battery-powered transportation.

(END) Dow Jones Newswires

December 04, 2018 02:48 ET (07:48 GMT)

Tesaro, Inc. (NASDAQ:TSRO)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024

Tesaro, Inc. (NASDAQ:TSRO)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024